In yesterday’s Wall Street session, Theravance Biopharma Inc (NASDAQ:TBPH) shares traded at $8.97, down -0.44% from the previous session.
TBPH stock price is now -0.70% away from the 50-day moving average and -7.77% away from the 200-day moving average. The market capitalization of the company currently stands at $432.00M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On May 23, 2022, SVB Leerink recently initiated its ‘Outperform’ rating on the stock quoting a target price of $12, while ‘JP Morgan’ rates the stock as ‘Neutral’
In other news, Farnum Rhonda, SVP, COMM & MEDICAL AFFAIRS sold 1,254 shares of the company’s stock on Feb 22 ’24. The stock was sold for $10,922 at an average price of $8.71. Upon completion of the transaction, the SVP, COMM & MEDICAL AFFAIRS now directly owns 311,733 shares in the company, valued at $2.8 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 21 ’23, SVP, COMM & MEDICAL AFFAIRS Farnum Rhonda sold 1,378 shares of the business’s stock. A total of $14,180 was realized by selling the stock at an average price of $10.29. This leaves the insider owning 331,206 shares of the company worth $2.97 million. A total of 7.85% of the company’s stock is owned by insiders.
During the past 12 months, Theravance Biopharma Inc has had a low of $8.21 and a high of $12.03. As of last week, the company has a debt-to-equity ratio of 0.23, a current ratio of 5.39, and a quick ratio of 5.39. The fifty day moving average price for TBPH is $9.03 and a two-hundred day moving average price translates $9.73 for the stock.
The latest earnings results from Theravance Biopharma Inc (NASDAQ: TBPH) was released for Dec, 2023. According to the Biotechnology Company, earnings per share came in at -$0.17, missing analysts’ expectations of -$0.15 by -0.02. This compares to $0.38 EPS in the same period last year. The net profit margin was -96.12% and return on equity was -16.86% for TBPH. The company reported revenue of $17.57 million for the quarter, compared to $14.65 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 19.91 percent. For the current quarter, analysts expect TBPH to generate $14.92M in revenue.
